Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

M. Hiligsmann, S. Maggi, N. Veronese, L. Sartori, J.Y. Reginster

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)595-606
Number of pages12
JournalOsteoporosis International
Volume32
Issue number3
DOIs
Publication statusPublished - 1 Mar 2021

Keywords

  • alendronate
  • buffered soluble alendronate
  • cost-effectiveness
  • economic evaluation
  • effervescent tablets
  • osteoporosis
  • treatment
  • Alendronate
  • Effervescent tablets
  • Osteoporosis
  • Treatment
  • Economic evaluation
  • Cost-effectiveness
  • Buffered soluble alendronate

Cite this